First License Granted for New CRISPR Systems

Alex Philippidis, GEN News Highlights, 13 November 2017,

Excision BioTherapeutics is the first to exclusively license the new CRISPR systems discovered by Jennifer Doudna’s group in 2016.  These new CRISPR systems were found in uncultivated microbes and are significantly smaller than Cas9, allowing for easier delivery into target cells.  These new CRISPR/Cas proteins do not interfere with the ongoing patent battle between UC-Berkeley and The Broad Institute, allowing for a much simpler patent landscape.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply